Methylation analysis of the DAPK1 gene in imatinibresistant chronic myeloid leukemia patients

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|1|399-404

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.1, 2015-01, pp. : 399-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients

By                    

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 181-187

Spandidos Publications

Access to resources Recommend Favorite

CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation

By                    

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 253-261

Spandidos Publications

Access to resources Recommend Favorite

Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer

By              

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1745-1750

Spandidos Publications

Access to resources Recommend Favorite

Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia

By Ni Ling-Na  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 265-269

Humana Press, Inc

Access to resources Recommend Favorite

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

By Al-Riyami Arwa Z.  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1788-1790

Informa Healthcare

Access to resources Recommend Favorite